作者: Nick J Spencer , Tim Hibberd , Jing Feng , Hongzhen Hu
DOI: 10.1080/17474124.2019.1581061
关键词:
摘要: Introduction: There are limited effective therapies available for improving gastrointestinal (GI) transit in mammals with intractable or chronic constipation. Current therapeutics to improve GI-transit usually require oral ingestion of therapeutic drugs, such as the serotonin receptor agonist prucalopride. However, most receptors distributed all over body and unsurprisingly drugs like prucalopride stimulate multiple organs, often leading unwanted side effects. is a desperate need community selectively without effects on other organs.Areas covered: We performed systematic review literature Pubmed report significant technical advances optogenetic control GI-tract. discuss recent demonstrations that optogenetics can be used potently activity subsets enteric neurons. Special focus made first demonstration wireless colon conscious, freely-mov...